Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine

Several reports of second malignant neoplasm (SMN) in patients with relapsed neuroblastoma after treatment with (131)I-MIBG suggest the possibility of increased risk. Incidence of and risk factors for SMN after (131)I-MIBG have not been defined. This is a multi-institutional retrospective review of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Eur J Cancer
Autori principali: Huibregtse, Kelly E., Vo, Kieuhoa T., DuBois, Steven G., Fetzko, Stephanie, Neuhaus, John, Batra, Vandana, Maris, John M., Weiss, Brian, Marachelian, Araz, Yanik, Greg A., Matthay, Katherine K.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523915/
https://ncbi.nlm.nih.gov/pubmed/27573428
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2016.07.017
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi